JT
Publicaties op Oncologisch.com
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with s...
Protonenradiotherapie Offers Immune-Sparing Benefits in Glioblastoom Behandeling
Multivariable Normal Tissue Complication Probability Voorspelling of Early Grade Radiation-Induced Optic Neuropathy Using Visual Field Deficit in a Prospectieve Pencil Bean Scanning Proton Therapy Cohort
Quality Assurance of Stereotactic Irradiation and Survival of Patiënten met Hoofd-hals Cancer in the A GORTEC 2014-04 “OMET” Gerandomiseerde Fase 2-Trial
Avelumab-cetuximab-RT versus standaardchemoradiatie bij lokaal gevorderd hoofd-halscarcinoom: GORTEC 2017-01